EW vs PRK · P/E 47, rev $1.39B vs P/E 16, rev $645.6M
Edwards Lifesciences Corp (EW) versus Park National Corporation (PRK) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Park National Corporation (PRK) is a banks - regional company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PRK revenue for 2024-12-31 was $645.6M. Net income was $151.4M. Revenue was up 14.4% from 2023-12-31 to 2024-12-31. PRK currently screens at market cap $3.13B and trailing P/E 15.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRK currently screens at market cap $3.13B and trailing P/E 15.9.
Not investment advice. Open the EW and PRK stock pages for the full models.
Not investment advice.